Variant report
Variant | esv3468868 |
---|---|
Chromosome Location | chr5:16124662-16125601 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:3)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:3 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr5:16124683-16124734 | HepG2 | liver: | n/a | chr5:16124714-16124725 |
2 | GATA3 | chr5:16124626-16125107 | SH-SY5Y | brain: | n/a | n/a |
3 | POLR2A | chr5:16125040-16125389 | H1-neurons | neurons: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000250981 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs559186333 | chr5:16124684-16124685 | Strong transcription Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs138646013 | chr5:16124686-16124687 | Strong transcription Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs534167962 | chr5:16124696-16124697 | Strong transcription Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs7722594 | chr5:16124766-16124767 | Strong transcription Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs558809240 | chr5:16124780-16124781 | Strong transcription Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs577262727 | chr5:16124783-16124784 | Strong transcription Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs149286832 | chr5:16124797-16124798 | Strong transcription Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs565869313 | chr5:16124810-16124811 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs556282464 | chr5:16124814-16124815 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs574393765 | chr5:16124815-16124816 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs145496702 | chr5:16124816-16124817 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs559731829 | chr5:16124821-16124822 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs188691588 | chr5:16124830-16124831 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs369114632 | chr5:16124837-16124838 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs7722777 | chr5:16124855-16124856 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs191468282 | chr5:16124897-16124898 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs78639956 | chr5:16124946-16124947 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs142483951 | chr5:16124992-16124993 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs145934655 | chr5:16125010-16125011 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs7723411 | chr5:16125026-16125027 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs7723420 | chr5:16125045-16125046 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs7722990 | chr5:16125047-16125048 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs530435226 | chr5:16125055-16125056 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs7705587 | chr5:16125067-16125068 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs548935574 | chr5:16125127-16125128 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs7705625 | chr5:16125142-16125143 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs148602085 | chr5:16125163-16125164 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs182173377 | chr5:16125182-16125183 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs534230455 | chr5:16125186-16125187 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs552532303 | chr5:16125187-16125188 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs111993833 | chr5:16125223-16125224 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs115418558 | chr5:16125230-16125231 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs141160679 | chr5:16125247-16125248 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs72738271 | chr5:16125321-16125322 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs568648682 | chr5:16125339-16125340 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs113637529 | chr5:16125346-16125347 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs150892971 | chr5:16125366-16125367 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs116079781 | chr5:16125380-16125381 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs139416853 | chr5:16125397-16125398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs116260634 | chr5:16125416-16125417 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs145546773 | chr5:16125421-16125422 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs147312073 | chr5:16125525-16125526 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs140795264 | chr5:16125529-16125530 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs144758067 | chr5:16125596-16125597 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 21364760 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Lung cancer | 16740712 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:16123400-16124800 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr5:16123400-16125400 | Weak transcription | Fetal Heart | heart |
3 | chr5:16124800-16127600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr5:16125400-16128200 | Enhancers | Fetal Heart | heart |
5 | chr5:16125600-16125800 | Enhancers | Left Ventricle | heart |